Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •Abstract
- •1.1 Introduction
- •1.1.1 Historical Background
- •1.3.2 Pulmonary Drug Delivery
- •1.3.3 Parenteral Drug Delivery
- •1.4 Inulin Health Benefits
- •1.4.1 Prebiotic Effects
- •1.5 Inulin Industrial Applications
- •1.5.2 Pharmaceutical Uses
- •1.6.2 Regulatory Status Worldwide
- •1.7.1 Emerging Health Benefits
- •1.8 Conclusion
- •References
- •1.3 Inulin Drug Delivery Routes
- •1.3.1 Oral Drug Delivery
- •Abstract
- •2.1 Introduction
- •2.4 Physicochemical Characteristics
- •2.4.1 Chain Length
- •2.4.2 Solubility
- •2.4.3 Viscosity
- •2.4.4 Melting Temperature
- •2.4.5 Gelling
- •2.5.1 Extraction Through Hot Water
- •2.5.2 Extraction Using Ultrasound
- •2.5.3 Extraction Directed Through Microwave
- •2.7.1 Therapeutic Benefits
- •2.7.1.2 As Laxative
- •2.7.1.3 In Lipid Metabolism
- •2.7.1.5 Absorption Enhancer
- •2.8 Pharmaceutical Benefits
- •2.8.3 In PEGylation
- •2.8.5 As Gel
- •2.9 Diagnostic Benefits
- •2.10.2 Yield Variability
- •2.10.3 Purity Challenges
- •2.11 Future Scope
- •2.12 Conclusion
- •References
- •Abstract
- •3.1 Introduction
- •3.2 Inulin-Based Drug Formulations
- •3.3.1 Inulin-Based Hydrogels
- •3.3.2 Inulin-Based Micelles
- •3.3.3 Inulin-Based Liposomes
- •3.3.4 Inulin-Based Prodrugs
- •3.3.5 Inulin-Based Chelating Agents
- •3.3.6 Inulin-Based Microparticles
- •3.3.7 Inulin-Based Nanoparticles
- •3.6 Conclusions
- •References
- •Abstract
- •4.1 Introduction
- •4.3.1 Emulsifying Properties
- •4.3.3 Particle Stabilization
- •4.5.1 Solid Dosage Forms
- •4.5.3 Parenteral Formulations
- •4.5.4 Drug Delivery Systems
- •4.6.1 Skin Care Products
- •4.6.2 Hair Care Products
- •4.6.3 Personal Hygiene Products
- •4.7.2 Blood Sugar Regulation
- •4.9 Conclusion
- •References
- •Abstract
- •5.1 Introduction
- •5.5 Inulin-Based Drug Delivery Systems
- •5.5.1 Inulin Film Coating Agents
- •5.5.2 Biodegradable Inulin Coatings
- •5.5.3 Multipulse Delivery
- •5.5.4 Functional Inulin Coating Materials
- •5.5.5 Inulin Enteric Coatings/Colon Targeting
- •5.5.6 Tumor Targeting
- •5.5.7 Inulin Sustained Release Coatings
- •5.5.8 Hybrid Inulin-Based Coating Materials
- •5.5.9 Inulin Taste-Masking Coatings
- •5.5.10 Nanotechnology Using Inulin
- •5.7.1 Agriculture
- •5.7.2 Diagnosis
- •5.7.3 MRI Diagnosis
- •5.7.4 Medicine
- •5.7.5 Bioremediation
- •References
- •Abstract
- •Abbreviations
- •6.1 Introduction
- •6.1.1 Background
- •6.2 Understanding Prebiotics
- •6.4.2 Fermentation by Gut Microbiota
- •6.6.1 Bidirectional Communication
- •6.8 Future Perspective
- •6.9 Conclusion
- •References
- •7.2.2 Anti-Inflammatory Effects
- •7.3.1 Skin Whiteners
- •7.3.2 Hair Care
- •7.4 Regulatory Status
- •7.5 Conclusion
- •References
- •Abstract
- •7.1 Introduction
- •Abstract
- •8.1 Introduction
- •8.2.3 Anatomical Characteristics
- •8.2.4 Thermodynamic Stability
- •8.4.2 Formulation Strategies
- •8.5.3 Regulatory Considerations
- •8.9 Regulatory Considerations
- •8.11 Conclusion
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Inulin-Based Pharmaceutical Applications
- •9.3.1.1 GIT
- •9.3.1.2 CNS
- •9.3.1.3 CVS
- •9.3.1.4 Hypersensitivity Reactions
- •9.3.1.5 Other Reported Adverse Effects
- •9.3.2 Inulin Interactions
- •9.4.1 Acceptable Daily Intake
- •9.4.3.2 Adults
- •9.4.3.3 Elderly Individuals
- •9.4.3.4 Pregnant or Lactating Women
- •9.5.1 Clinical Trial Outcome
- •9.5.2 Animal Studies
- •9.5.3 In Vitro Studies
- •9.6 Future Prospects
- •9.7 Conclusion
- •References
- •Abstract
- •Abbreviations
- •10.1 Introduction
- •10.2.2.1 Prebiotic Activity
- •10.2.2.2 Improved Gut Health
- •10.2.2.3 Anti-Inflammatory Effects
- •10.2.2.5 Enhanced Mineral Absorption
- •10.6.1 Potential Side Effects
- •10.6.2 Dosage Recommendations
- •10.7 Future Perspective
- •10.8 Conclusion
- •References
- •Abstract
- •11.19.1 Tolerance
- •11.20 Conclusion
- •References
- •Abstract
- •12.1 Introduction
- •12.5.1 Hydrogels
- •12.5.2 Microparticles
- •12.5.3 Nanoparticles
- •12.5.4 Inulin Conjugates
- •12.5.5 Miscellaneous
- •12.7 Conclusion
- •References
- •Abstract
- •13.5.1 Pharmaceutical Quality Assurance Framework
- •References
- •Abstract
- •14.1 Introduction
- •14.2.1 Prebiotic Nature
- •14.8 Immune-Modulatory Effects
- •14.9.3 Addressing Bone-Related Disorders
- •14.12 Cognitive Implications
- •14.13 Future Directions
- •14.14 Conclusion
- •References
- •Abstract
- •15.1 Introduction
- •15.3 Extraction Techniques
- •15.7.1 In Pharmaceutical Sector
- •15.7.1.4 As Vaccine Adjuvant
- •15.7.2 In Food Sector
- •References
- •Abstract
- •16.1 Introduction
- •16.1.3 Innovative Drug Delivery Systems
- •16.2 Functional Properties
- •16.2.1 Liquidity
- •16.2.2 Prebiotic Characteristics
- •16.2.3 Low Energy Density
- •16.2.5 Potential Health Benefits
- •16.3.3 Mucosal Delivery Systems
- •16.3.4 Liposomes
- •16.5 Future Perspectives
- •References

207
use in the food industry by reaching a wider range of consumers (Abed etal. 2016).
Biodegradable and biocompatible nature makes it useful for various biomedical
purposes including tissue engineering, diagnostic imaging, and drug delivery sys-
tems. There is potentiality for future researches on novel formulations and modes of
treatment to improve efciency and minimize adverse effects associated with medi-
cal applications (Anjuomo etal. 2019). Increased investigations into the medicinal
properties of inulin may reveal new therapeutic functions apart from its benets on
the intestinal microora. Apart from the gut health aspects, there is likely that scien-
tists will want to examine if it has any implications as far as metabolic health, heart-
related conditions, and immune function are concerned. Such ndings may support
tailored nutritional approaches and dietary recommendations.
Tailored dietary guidelines may be inuenced by inulin’s impact on unique gut
microbiota as the personalized nutrition eld gains traction. In the future, nutritional
composition based on an individual’s microbiome makeup could become a more
popular approach to personalizing diets with inulin being suggested for certain
health objectives (Anjuomo etal. 2019). Nutraceuticals products combining nutri-
tional and pharmaceutical attributes may require more use of inulin in their formula-
tions. For example, designing supplements or drug products to specically target
and manipulate gut microbiota as a means of therapy can be done (Abreu etal.
2022). Some people might opt for using it since sugar alternatives are healthy and
yet sweet at all without any calorie content like that of inulin. Future developments
could also involve improving its sweetness prole through rening production pro-
cesses and including it in a larger variety of foods and beverages. Hence, one would
expect an increase in sustainable sourcing and production practices for inulin espe-
cially amidst growing concerns about sustainability. Additionally, there is an oppor-
tunity for scientists and industry players involved in this production value chain to
explore greener extraction methods as well as alternative sources of inulin so as to
minimize its environmental footprint. As inulin is used throughout industries,
dened regulatory frameworks will be needed to ensure its safety and efcacy
(Illippangama etal. 2022). Researchers, industry stakeholders, and regulatory bod-
ies may work together to set inulin-based product production and use standards.
Standardized denitions, labeling requirements, and recommended daily allow-
ances could be developed to ensure consumer safety and transparency (Delzenne
etal. 2002).
10.8 Conclusion
Consumers are more health-conscious and demanding low-calorie foods with supe-
rior health benets in the modern era. The present investigations have yielded a
comprehensive understanding of the signicance of recently identied active com-
ponents in the formulation of functional foods. While there has been some investi-
gation into the function of inulin in recent years, this review primarily examined its
nutritional and health benets, as well as its applications in food, with a particular
emphasis on its utilization as a functional food. As both a dietary ber and a
10 Role ofInulin intheManagement ofMetabolic Disorders

208
prebiotic, inulin is an exceptionally prospective functional food that benets human
health tremendously. In addition to preventing obesity, diabetes, colon cancer, con-
stipation, and depression, inulin exhibits considerable promise as a preventative
agent against these conditions and may be utilized in the future as a supplement in
the treatment of others. Furthermore, research has demonstrated that the therapeutic
effects of inulin are enhanced when it is combined with specic natural products.
This nding introduces the notion that compound products generally offer more
substantial health benets compared to individual substances. Subsequently, the
implementation of composite products will emerge as a prominent domain within
the realm of functional foods. While further investigations are warranted to eluci-
date specic molecular pathways and optimize dosages, the cumulative evidence
supports that inulin could serve as a valuable tool in the holistic management and
prevention of metabolic disorders, offering a natural and accessible avenue to pro-
mote metabolic well-being.
References
Abed SM, Ali AH, Noman A, Bakry AM (2016) Inulin as prebiotics and its applications in food
industry and human health; A review. Int J Agric Innov Res 5(Pt 1):88–97
Abreu CDD, Caldas BV, Ribeiro GHM, Aguilar CM, Farias LC, Guimarães ALS, de Paula AMB,
Glória MBA, Santos SHS (2022) Inulin prebiotic dietary supplementation improves metabolic
parameters by reducing the Toll-like receptor 4 transmembrane protein gene and interleu-
kin 6 expression in adipose tissue. Pharma Nutr 22(Pt 1):100–316. https://doi.org/10.1016/j.
phanu.2022.100316
Anjuomo F, Barclay TG, Song Y, Parikh A, Petrovsky N, Garg S (2019) Synthesis and charac-
terization of a novel inulin hydrogel crosslinked with pyromellitic dianhydride. React Funct
Polym 134:104–111. https://doi.org/10.1016/j.reactfunctpolym.2018.10.014
Afroja S, Falgunee FN, Jahan MM, Akanda KM, Mehjabin S, Parvez GMM (2017) Antibacterial
activity of different citrus fruits, specialty journal of medical research and health. Science 2(Pt
2):25–32
Akanda MKM, Hasan AHMN (2021) Characterization of pharmacological properties of metha-
nolic seed and stem bark extracts of Ziziphus mauritiana (BAU Kul) using in-vitro and in-vivo
animal (Swiss albino male mice) model. Clin Phytoscience 7(Pt1):8. https://doi.org/10.1186/
s40816- 020- 00246- 0
Akanda MKM, Sultana R, Rana MM, Hossain MA, Barik SMA, Islam MR, Islam MN, Parvez
GMM (2024) Prevalence, causes, and management strategies of fungal diseases in Northern
Regions of Bangladesh. Sci Pharm 3(Pt 1):24–33. https://doi.org/10.58920/sciphar0301191
Akanda KM, Mehjabin S (2024) Potential role of probiotics, prebiotics and synbiotics in manage-
ment of metabolic syndrome and chronic metabolic disease. In: Mishra N, Ashique S, Farid A,
Garg A (eds) Applications of synbiotics in metabolic disorder management. CRC Press/Taylor
& Francis Group, Inc., Boca Raton, FL, pp39–54
Akter MR, Akanda MKM, Islam MS, Rana MM (2020) Assessment of drug utilization pattern
among outpatients in the orthopedic department of several private clinics in Rajshahi city,
Bangladesh. Int J Pharm Sci Res 5(Pt 4):13–16
An L, Yang JC, Yin H, Xue R, Wang Q, Sun YC, Zhang YZ, Yang M (2016) Inulin-type oligo-
saccharides extracted from Yacon produce antidepressant-like effects in behavioral models of
depression. Phytother Res 30(Pt 12):1937–1942. https://doi.org/10.1002/ptr.5698
Benyacoub J, Rochat F, Saudan KY, Rochat I, Antille N, Cherbut C, von der Weid T, Schiffrin EJ,
Blum S (2008) Feeding a diet containing a fructooligosaccharide mix can enhance salmonella
vaccine efcacy in Mice1. J Nutr 138(Pt 1):123–129. https://doi.org/10.1093/jn/138.1.123
S. Mehjabin et al.

209
Boeckner LS, Schnepf MI, Tungland BC (2001) Inulin: a review of nutritional and health implica-
tions. Adv Food Nutr Res 43:1–63. https://doi.org/10.1016/s1043- 4526(01)43002- 6
Bonnema AL, Kolberg LW, Thomas W, Slavin JL (2010) Gastrointestinal tolerance of chicory inu-
lin products. J Am Diet Assoc 110(Pt 6):865–868. https://doi.org/10.1016/j.jada.2010.03.025
Brooks L, Viardot A, Tsakmaki A, Stolarczyk E, Howard JK, Cani PD etal (2017) Fermentable
carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Mol
Metab 6(Pt 1):48–60. https://doi.org/10.1016/j.molmet.2016.10.011
Bunout D, Barrera G, Hirsch S, Gattas V, de la Maza M, Haschke F etal (2004) Effects of a nutritional
supplement on the immune response and cytokine production in free-living Chilean elderly. J
Parenter Enter Nutr 28(Pt 5):348–354. https://doi.org/10.1177/0148607104028005348
Chaiyasut C, Sivamaruthi BS, Kesika P, Khongtan S, Khampithum N, Thangaleela S (2021)
Synbiotic supplementation improves obesity index and metabolic biomarkers in thai obese
adults: a randomized clinical trial. Food Secur 10(Pt 7):1580. https://doi.org/10.3390/
foods10071580
Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK etal (2015)
Effects of targeted delivery of propionate to the human colon on appetite regulation, body
weight maintenance and adiposity in overweight adults. Gut 64(Pt 11):1744–1754. https://doi.
org/10.1136/gutjnl- 2014- 307913
Chao S, Priscilla S (2009) Inulin. In: Fiber ingredients: food applications and health benets, 1st
edn. CRC Press, Boca Raton, FL, pp41–55
Closa-Monasterolo R, Ferré N, Castillejo-DeVillasante G, Luque V, Gispert-Llaurado M,
Zaragoza-Jordana M etal (2017) The use of inulin-type fructans improves stool consistency
in constipated children. A randomised clinical trial: pilot study. Int J Food Sci Nutr 68(Pt
5):587–594. https://doi.org/10.1080/09637486.2016.1263605
Coulthard MG, Ruddock V (1983) Validation of inulin as a marker for glomerular ltration in
preterm babies. Kidney Int 23(Pt 2):407–409. https://doi.org/10.1038/ki.1983.34
Coussement PAA (1999) Inulin and oligofructose: safe intakes and legal status. J Nutr
129(Pt7):1412S–1417S. https://doi.org/10.1093/jn/129.7.1412S
Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T etal (2000) Ghrelin, a
novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell
type in the gastrointestinal tracts of rats and humans. Endocrinology 141(Pt 11):4255–4261.
https://doi.org/10.1210/endo.141.11.7757
Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ et al
(2019) Prebiotics: denition, types, sources, mechanisms, and clinical applications. Food
Secur 8(Pt 3):92. https://doi.org/10.3390/foods8030092
Dehghan P, Gargari BP, Jafar-Abadi MA, Aliasgharzadeh A (2014) Inulin controls inamma-
tion and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-con-
trolled clinical trial. Int J Food Sci Nutr 65(Pt 1):117–123. https://doi.org/10.3109/0963748
6.2013.836738
Delzenne NM, Daubioul C, Neyrinck A, Lasa M, Taper HS (2002) Inulin and oligofructose modu-
late lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr
87(Suppl 2):S255–S259. https://doi.org/10.1079/BJNBJN/2002545
Delzenne NM, Cani PD, Daubioul C, Neyrinck AM (2005) Impact of inulin and oligofruc-
tose on gastrointestinal peptides. Br J Nutr 93(Pt S1):S157–SS61. https://doi.org/10.1079/
BJN20041342
Forcheron F, Beylot M (2007) Long-term administration of inulin-type fructans has no signicant
lipid-lowering effect in normolipidemic humans. Metab Clin Exp 56(Pt 8):1093–1098. https://
doi.org/10.1016/j.metabol.2007.03.019
Foster JA, Neufeld KAM (2013) Gut–brain axis: how the microbiome inuences anxiety and
depression. Trends Neurosci 36(Pt 5):305–312. https://doi.org/10.1016/j.tins.2013.01.005
Franck A (2002) Technological functionality of inulin and oligofructose. Br J Nutr 87(Suppl
2):S287–S291. https://doi.org/10.1079/BJNBJN/2002550
Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV etal (2005) Synbiotic therapy
(Bidobacterium longum/synergy 1) initiates resolution of inammation in patients with
10 Role ofInulin intheManagement ofMetabolic Disorders

210
active ulcerative colitis: a randomised controlled pilot trial. Gut 54(Pt 2):242–249. https://doi.
org/10.1136/gut.2004.044834
García Contreras AA, Vásquez Garibay EM, Sánchez Ramírez CA, Fafutis Morris M, Delgado
Rizo V (2020) Lactobacillus reuteri DSM 17938 and agave inulin in children with cerebral
palsy and chronic constipation: a double-blind randomized placebo controlled clinical trial.
Nutrients 12(Pt 10):2971. https://doi.org/10.3390/nu12102971
Ghavami A, Roshanravan N, Alipour S, Barati M, Mansoori B, Ghalichi F etal (2018) Assessing the
effect of high performance inulin supplementation via KLF5 mRNA expression in adults with
type 2 diabetes: a randomized placebo controlled clinical trail. Adv Pharm Bull 8(1):39–47.
https://doi.org/10.15171/apb.2018.005
Gupta N, Jangid AK, Pooja D, Kulhari H (2019) Inulin: a novel and stretchy polysaccharide tool
for biomedical and nutritional applications. Int J Biol Macromol 132:852–863. https://doi.
org/10.1016/j.ijbiomac.2019.03.188
Haque MU, Ahmmed SB, Akanda MKM, Hasan MT, Mou SA, Sajon SR etal (2016) Prevalence
and risk factors of obesity and hypertension among university students in Rajshahi City,
Bangladesh Bangladesh. Pharm J 19(Pt 2):179–184. https://doi.org/10.3329/bpj.v19i2.29277
He Y, Wu C, Li J, Li H, Sun Z, Zhang H etal (2017) Inulin-type fructans modulates pancreatic–gut
innate immune responses and gut barrier integrity during experimental acute pancreatitis in a
chain length-dependent manner. Front Immunol 8:1209
He J, Zhang P, Shen L, Niu L, Tan Y, Chen L etal (2020) Short-chain fatty acids and their associa-
tion with signalling pathways in inammation, glucose and lipid metabolism. Int J Mol Sci
21(Pt 17):6356. https://doi.org/10.3390/ijms21176356
He J, Xie H, Chen D, Huang BZ etal (2021) Synergetic responses of intestinal microbiota and
epithelium to dietary inulin supplementation in pigs. Eur J Nutr 60(Pt 2):715–727. https://doi.
org/10.1007/s00394- 020- 02284- 3
Hegar B, Boediarso A, Firmansyah A, Vandenplas Y (2004) Investigation of regurgitation and
other symptoms of gastroesophageal reux in Indonesian infants. World J Gastroenterol 10(Pt
12):1795–1797. https://doi.org/10.3748/wjg.v10.i12.1795
Hiel S, Neyrinck AM, Rodriguez J, Pachikian BD, Bouzin C etal (2018) Inulin improves postpran-
dial hypertriglyceridemia by modulating gene expression in the small intestine. Nutrients 10(Pt
5):532. https://doi.org/10.3390/nu10050532
Hijová E, Szabadosova V, Štolová J, Hrčková G (2013) Chemopreventive and metabolic effects
of inulin on colon cancer development. J Vet Sci 14(Pt 4):387–393. https://doi.org/10.4142/
jvs.2013.14.4.387
Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR (2019) Theberge gut
microbiome: profound implications for diet and disease. Nutrients 11(Pt 7):1613. https://doi.
org/10.3390/nu11071613
Hoving LR, De Vries MR, De Jong RCM, Katiraei S, Pronk A, Quax PHA etal (2018) The pre-
biotic inulin aggravates accelerated atherosclerosis in hypercholesterolemic APOE*3-leiden
mice. Nutrients 10(Pt 2):172. https://doi.org/10.3390/nu10020172
Hsu CY, Bansal N (2011) Measured GFR as “gold standard” all that glitters is not gold? Clin J Am
Soc Nephrol 6(Pt 8):1813–1814. https://doi.org/10.2215/CJN.06040611
Hume MP, Nicolucci AC, Reimer RA (2017) Prebiotic supplementation improves appetite control
in children with overweight and obesity: a randomized controlled trial1, 2, 3. Am J Clin Nutr
105(Pt 4):790–799. https://doi.org/10.3945/ajcn.116.140947
Illippangama AU, Jayasena DD, Jo C, Mudannayake DC (2022) Inulin as a functional ingredi-
ent and their applications in meat products. Carbohydr Polym 275:118–706. https://doi.
org/10.1016/j.carbpol.2021.118706
Imeson A (2010) Food stabilisers, thickeners and gelling agents. Blackwell Publishing Ltd., Oxford
Irvine JC, Soutar CW (1920) CLXV.The constitution of polysaccharides. Part II.The conversion
of cellulose into glucose. J Chem Soc Trans 117(Pt 1):1489–1500. https://doi.org/10.1039/
CT9201701489
Irvine JC, Stevenson JW (1929) The molecular structure of inulin. Isolation of a new anhydrofruc-
tose. J Am Chem Soc 51(Pt 7):2197–2203. https://doi.org/10.1021/ja01382a035
S. Mehjabin et al.

211
Jarienė E (2022) Prospects for inulin processing. In: Sawicka B, Krochmal-Marczak B (eds)
Jerusalem artichoke food science and technology: helianthus tuberosus. Springer Nature,
Singapore, pp241–251
Kelly-Quagliana KA, Nelson PD, Buddington RK (2003) Dietary oligofructose and inulin
modulate immune functions in mice. Nutr Res 23(Pt 2):257–267. https://doi.org/10.1016/
S0271- 5317(02)00516- X
Kip P, Meyer D, Jellema RH (2006) Inulins improve sensoric and textural properties of low-fat
yoghurts. Int Dairy J 16(Pt 9):1098–1103. https://doi.org/10.1016/j.idairyj.2005.10.011
Koleva PT, Valcheva RS, Sun X, Gänzle MG, Dieleman LA (2012) Inulin and fructo-oligosaccha-
rides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats.
Br J Nutr 108(Pt 9):1633–1643. https://doi.org/10.1017/S0007114511007203
Leach JD, Sobolik KD (2010) High dietary intake of prebiotic inulin-type fructans in the pre-
historic Chihuahuan Desert. Br J Nutr 103(Pt 11):1558–1561. https://doi.org/10.1017/
S0007114510000966
Lee SH, Kwon J, Cho ML (2018) Immunological pathogenesis of inammatory bowel disease.
Intest Res 16(Pt 1):26–42. https://doi.org/10.5217/ir.2018.16.1.26
Legette LL, Lee W, Martin BR, Story JA, Campbell JK, Weaver CM (2012) Prebiotics
enhance magnesium absorption and inulin-based bers exert chronic effects on cal-
cium utilization in a postmenopausal rodent model. J Food Sci 77(Pt 4):88–94. https://doi.
org/10.1111/j.1750- 3841.2011.02612.x
Lepczyński A, Herosimczyk A, Barszcz M, Ożgo M, Michałek K, Grabowska M etal (2021) Diet
supplemented either with dried chicory root or chicory inulin signicantly inuence kidney
and liver mineral content and antioxidative capacity in growing pigs. Animal 15(Pt 2):100129.
https://doi.org/10.1016/j.animal.2020.100129
Letexier D, Diraison F, Beylot M (2003) Addition of inulin to a moderately high-carbohydrate diet
reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin
Nutr 77(Pt 3):559–564. https://doi.org/10.1093/ajcn/77.3.559
Leyrolle Q, Cserjesi RDGH, Mulders G, Zamariola S, Hiel MA etal (2021) Prebiotic effect on
mood in obese patients is determined by the initial gut microbiota composition: a randomized,
controlled trial. Brain Behav Immun 94:289–298. https://doi.org/10.1016/j.bbi.2021.01.014
Li BY, Xu XY, Gan RY, Sun QC, Meng JM, Shang A, Mao QQ, Li HB (2019) Targeting gut micro-
biota for the prevention and management of diabetes mellitus by dietary natural products. Food
Secur 8(Pt 10):440. https://doi.org/10.3390/foods8100440
Li L, Zhang L, Zhou L, Jin M, Xu L (2021) Chain length-dependent inulin alleviates diet-induced
obesity and metabolic disorders in mice. Food Sci Nutr 9(Pt 7):3470–3482. https://doi.
org/10.1002/fsn3.2283
Lightowler H, Thondre S, Holz A, Theis S (2018) Replacement of glycaemic carbohydrates by
inulin-type fructans from chicory (oligofructose, inulin) reduces the postprandial blood glu-
cose and insulin response to foods: report of two double-blind, randomized, controlled trials.
Eur J Nutr 57(Pt 3):1259–1268. https://doi.org/10.1007/s00394- 017- 1409- z
Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N (2006) Clinical, microbio-
logical, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease.
Gut 55(Pt 3):348–355. https://doi.org/10.1136/gut.2005.074971
Liu X, Yang Q, He Z, Yao S (2021) Efcacy and safety of inulin supplementation for func-
tional constipation: a systematic review protocol. BMJ Open 11(Pt 4):e042597. https://doi.
org/10.1136/bmjopen- 2020- 042597
Makki K, Deehan EC, Walter J, Bäckhed F (2018) The impact of dietary ber on gut microbiota
in host health and disease. Cell Host Microbe 23(Pt 6):705–715. https://doi.org/10.1016/j.
chom.2018.05.012
Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B (2011) Effects of chicory
inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr 62(Pt
2):164–170. https://doi.org/10.3109/09637486.2010.527323
Mehjabin S, Akanda MK, Hoque N, Hasan AHMN, Parvez M, Mosaddik A (2024a) Flavonoid
intake and risk of toxicity in chronic metabolic diseases. In: Mishra N, Ashique S, Garg A (eds)
Role of avonoids in chronic metabolic diseases: from bench to clinic. Wiley, pp511–534
10 Role ofInulin intheManagement ofMetabolic Disorders

212
Mehjabin S, Akanda KM, Hasan AHMN, Parvez M (2024b) Synbiotics: present status and future
prospectives to control metabolic disorders. In: Mishra N, Ashique S, Farid A, Garg A (eds)
Applications of synbiotics in metabolic disorder management. CRC Press, Taylor & Francis
Group, Inc., USA, pp245–256
Menegas LZ, Pimentel TC, Garcia S, Prudencio SH (2013) Dry-fermented chicken sausage pro-
duced with inulin and corn oil: physicochemical, microbiological, and textural characteris-
tics and acceptability during storage. Meat Sci 93(Pt3):501–506. https://doi.org/10.1016/j.
meatsci.2012.11.003
Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ (2015) Inulin, a exible
oligosaccharide. II: review of its pharmaceutical applications. Carbohydr Polym 134:418–428.
https://doi.org/10.1016/j.carbpol.2015.08.022
Mistry RH, Gu F, Schols HA, Verkade HJ, Tietge UJF (2018) Effect of the prebiotic ber inu-
lin on cholesterol metabolism in wildtype mice. Sci Rep 8(Pt 1):1–8. https://doi.org/10.1038/
s41598- 018- 31698- 7
Morimoto MM, Suto A, Nakatani A, Hayakawa T, Hara K, Kimura I (2020) Synthetic dietary
inulin, Fuji FF, delays development of diet-induced obesity by improving gut microbiota pro-
les and increasing short-chain fatty acid production. Peer J 8:e8893. https://doi.org/10.7717/
peerj.8893
Moshfegh AJ, Friday JE, Goldman JP, Ahuja JK (1999) Presence of inulin and oligofructose
in the diets of Americans. J Nutr 129(7 Suppl):1407S–1411S. https://doi.org/10.1093/
jn/129.7.1407S
Myhill LJ, Stolzenbach S, Mejer H, Jakobsen SR, Hansen TVA, Andersen D et al (2020)
Fermentable dietary ber promotes helminth infection and exacerbates host inammatory
responses. J Immunol 204(Pt 11):3042–3055. https://doi.org/10.4049/jimmunol.1901149
Nair KK, Kharb S, Thompkinson DK (2010) Inulin dietary ber with functional and health attri-
butes—a review. Food Rev Intl 26(Pt 2):189–203. https://doi.org/10.1080/87559121003590664
Nicolucci AC, Hume MP, Martínez I, Mayengbam S, Walter J, Reimer RA (2017) Prebiotics
reduce body fat and Alter intestinal microbiota in children who are overweight or with obe-
sity. Gastroenterology 153(Pt 3):711–722. https://doi.org/10.1053/j.gastro.2017.05.055
Niness KR (1999) Inulin and oligofructose: what are they? J Nutr 129(Pt 7):1402S–1406S. https://
doi.org/10.1093/jn/129.7.1402S
Ning C, Wang X, Gao S, Mu J, Wang Y, Liu S, Zhu J, Meng X (2017) Chicory inulin ameliorates
type 2 diabetes mellitus and suppresses JNK and MAPK pathways invivo and invitro. Mol
Nutr Food Res 61(Pt 8):1600673. https://doi.org/10.1002/mnfr.201600673
Norvell A (2013) Components of the immune system. In: Prendergast GC, Jaffee EM (eds) Cancer
immunotherapy, 2nd edn. Academic Press, San Diego, CA, pp11–24
Parvez MGM, Akanda KM (2019) Chapter 1—Foods and arthritis: an overview. In: Watson RR,
Preedy VR (eds) Bioactive food as dietary interventions for arthritis and related inammatory
diseases (second edition). Academic Press, pp3–22
Parvez GMM, Akanda KM, Karim R, Mou SM, Zahan P, Mosaddik DA (2016) Comparative
phytochemical screening and antimicrobial evaluation of different varieties of banana (Musa
sapientum). Int J Innov Pharm Sci Res 4(Pt 4):372–383
Parvez GM, Sultana R, Akanda MKM, Mehjabin S, Mosaddik A (2017) Nature and cause of tak-
ing psychotropic drugs: a cross-sectional health survey in northern regions of Bangladesh. Int
J Pharm Sci Res 9(Pt 1):361–368
Pattananandecha T, Sirilun S, Duangjitcharoen Y, Sivamaruthi BS, Suwannalert P, Peerajan S,
Chaiyasut C (2016) Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic
aberrant crypt foci by altering selected intestinal microbiota in Sprague–Dawley rats. Pharm
Biol 54(Pt 9):1596–1605. https://doi.org/10.3109/13880209.2015.1110597
Pauly MJ, Rohde JK, John C, Evangelakos I, Koop AC, Pertzborn P etal (2020) Inulin supple-
mentation disturbs hepatic cholesterol and bile acid metabolism independent from housing
temperature. Nutrients 12(Pt 10):3200. https://doi.org/10.3390/nu12103200
Qamar TR, Syed F, Nasir M, Rehman H, Zahid MN, Liu RH, Iqbal S (2016) Novel combina-
tion of prebiotics galacto-oligosaccharides and inulin-inhibited aberrant crypt foci formation
S. Mehjabin et al.

213
and biomarkers of colon cancer in Wistar rats. Nutrients 8(Pt 8):465. https://doi.org/10.3390/
nu8080465
Richards AN, Westfall BB, Bott PA (1934) Renal excretion of inulin, creatinine and xylose in nor-
mal dogs. Proc Soc Exp Biol Med 32(Pt1):73–75. https://doi.org/10.3181/00379727- 32- 7564P
Roberfroid MB (1999) Caloric value of inulin and oligofructose. J Nutr 129(Pt
7):1436S–1437S. https://doi.org/10.1093/jn/129.7.1436S
Roberfroid MB (2002) Functional foods: concepts and application to inulin and oligofructose. Br
J Nutr 87(Suppl 2):S139–S143. https://doi.org/10.1079/BJNBJN/2002529
Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137(11
Suppl):2493S–2502S. https://doi.org/10.1093/jn/137.11.2493S
Roshanravan N, Mahdavi R, Alizadeh E, Ghavami A, Saadat YR, Alamdari NM et al (2017a)
The effects of sodium butyrate and inulin supplementation on angiotensin signaling path-
way via promotion of Akkermansia muciniphila abundance in type 2 diabetes; a randomized,
double-blind, placebo-controlled trial. J Cardiovasc Thorac Res 9(Pt 4):183–190. https://doi.
org/10.15171/jcvtr.2017.32
Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A etal (2017b)
Effect of butyrate and inulin supplementation on glycemic status, lipid prole and glucagon-
like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-con-
trolled trial. Horm Metab Res 49(Pt 11):886–891. https://doi.org/10.1055/s- 0043- 119089
Schaafsma G, Slavin JL (2015) Signicance of inulin fructans in the human diet. Compr Rev Food
Sci Food Saf 14(Pt 1):37–47. https://doi.org/10.1111/1541- 4337.12119
Schultz M, Munro K, Tannock GW, Melchner I, Göttl C, Schwietz Schölmerich HJ, Rath HC
(2004) Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of
colitis and on the composition of the intestinal microora in HLA-B27 transgenic rats. Clin
Vaccine Immunol 11(Pt 3):581–587. https://doi.org/10.1128/CDLI.11.3.581- 587.2004
Shao T, Yu Q, Zhu T, Liu A, Gao X, Long X, Liu Z (2020) Inulin from Jerusalem artichoke tubers
alleviates hyperglycaemia in high-fat-diet-induced diabetes mice through the intestinal micro-
ora improvement. Br J Nutr 123(3):308–318. https://doi.org/10.1017/S0007114519002332
Slavin JL (2005) Dietary ber and body weight. Nutrition 21(Pt 3):411–418. https://doi.
org/10.1016/j.nut.2004.08.018
Slavin J, Feirtag J (2011) Chicory inulin does not increase stool weight or speed up intestinal transit
time in healthy male subjects. Food Funct 2(Pt 1):72–77. https://doi.org/10.1039/C0FO00101E
Smith AP, Sutherland D, Hewlett P (2015) An investigation of the acute effects of oligofructose-
enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients 7(Pt
11):8887–8896. https://doi.org/10.3390/nu7115441
Smitka K, Papezova H, Vondra K, Hill M, Nedvidkova VJ (2013) The role of “mixed” orexigenic
and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides
and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status
in patients with anorexia nervosa and bulimia nervosa. Int J Endocrinol 23(Pt 1):2–21. https://
doi.org/10.1155/2013/483145
Sobol M, Raj S, Skiba G (2018) Inulin supplementation reduces the negative effect of a high-fat
diet rich in SFA on bone health of growing pigs. Br J Nutr 119(Pt 10):1111–1118. https://doi.
org/10.1017/S0007114518000764
Sommer F, Bäckhed F (2013) The gut microbiota—masters of host development and physiology.
Nat Rev Microbiol 11(Pt 4):227–238. https://doi.org/10.1038/nrmicro2974
Song X, Zhong L, Lyu N, Liu F, Li B, Hao Y etal (2019) Inulin can alleviate metabolism dis-
orders in ob/ob mice by partially restoring leptin-related pathways mediated by gut micro-
biota. Genomics Proteomics Bioinformatics 17(Pt 1):64–75. https://doi.org/10.1016/j.
gpb.2019.03.001
Sultana R, Akanda KM, Mehjabin S, Parvez GMM (2017) Prescribing trends of psychotropic
drugs in northern Bangladesh. Spec J Med Res Health Sci 2(Pt 2):17–25
Tarini J, Wolever TMS (2010) The fermentable bre inulin increases postprandial serum short-
chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr
Metab 35(Pt 1):9–16. https://doi.org/10.1139/H09- 119
10 Role ofInulin intheManagement ofMetabolic Disorders

214
Teuri U, Kärkkäinen M, Lamberg-Allardt C, Korpela R (2000) Addition of inulin to breakfast does
not acutely affect serum ionized calcium and parathyroid hormone concentrations. Ann Nutr
Metab 43(Pt 6):356–364. https://doi.org/10.1159/000012804
Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS etal (2022) Heart
disease and stroke statistics-2022 update: a report from the American Heart Association.
Circulation 145(Pt 8):e153–e639. https://doi.org/10.1161/CIR.0000000000001052
Uzzaman S, Akanda KM, Mehjabin S, Parvez GMM (2018) A short review on a nutritional fruit:
guava. Open Access Toxicol Res 1(Pt 1):1–8
Valluru R, Van den Ende W (2008) Plant fructans in stress environments: emerging concepts and
future prospects. J Exp Bot 59(Pt 11):2905–2916. https://doi.org/10.1093/jxb/ern164
Verma A, Shukla G (2013) Administration of prebiotic inulin suppresses 1,2 dimethylhydrazine
dihydrochloride induced procarcinogenic biomarkers fecal enzymes and preneoplastic lesions
in early colon carcinogenesis in Sprague Dawley rats. J Funct Foods 5(Pt 2):991–996. https://
doi.org/10.1016/j.jff.2013.02.006
Visuthranukul C, Chamni S, Kwanbunbumpen T, Saengpanit P, Chongpison Y, Tepaamorndech S
etal (2022) Effects of inulin supplementation on body composition and metabolic outcomes
in children with obesity. Sci Rep 12(Pt 1):13014. https://doi.org/10.1038/s41598- 022- 17220- 0
Wang D, Liu CD, Tian ML, Tan CQ, Shu G, Jiang QY etal (2019) Propionate promotes intesti-
nal lipolysis and metabolic benets via AMPK/LSD1 pathway in mice. J Endocrinol 243(Pt
3):187–193. https://doi.org/10.1530/JOE- 19- 0188
Watson AW, Houghton D, Avery PJ, Stewart C, Vaughan EE, Meyer PD et al (2019) Changes
in stool frequency following chicory inulin consumption, and effects on stool consistency,
quality of life and composition of gut microbiota. Food Hydrocoll 96:688–698. https://doi.
org/10.1016/j.foodhyd.2019.06.006
Williams CM, Jackson KG (2002) Inulin and oligofructose: effects on lipid metabolism from
human studies. Br J Nutr 87(Suppl 2):S261–S264. https://doi.org/10.1079/BJNBJN/2002546
Wilson B, Whelan K (2017) Prebiotic inulin-type fructans and galacto-oligosaccharides: deni-
tion, specicity, function, and application in gastrointestinal disorders. J Gastroenterol Hepatol
32(Pt S1):64–68. https://doi.org/10.1111/jgh.13700
Yang J, Zhang S, Henning SM, Lee R, Hsu M, Grojean E etal (2018) Cholesterol-lowering effects
of dietary pomegranate extract and inulin in mice fed an obesogenic diet. J Nutr Biochem
52:62–69. https://doi.org/10.1016/j.jnutbio.2017.10.003
Zimeri JE, Kokini JL (2002) The effect of moisture content on the crystallinity and glass tran-
sition temperature of inulin. Carbohydr Polym 48(Pt 3):299–304. https://doi.org/10.1016/
S0144- 8617(01)00260- 0
Zou J, Reddivari L, Shi Z, Li S, Wang Y, Bretin A etal (2021) Inulin fermentable ber amelio-
rates type I diabetes via IL22 and short-chain fatty acids in experimental models. Cell Mol
Gastroenterol Hepatol 12(Pt 3):983–1000. https://doi.org/10.1016/j.jcmgh.2021.04.014
S. Mehjabin et al.

215
11
Inulin andGastrointestinal Disorders
SunilKumarKadiri, PrashantTiwari,
DeepakS.Khobragade, andDhritijaSathavalli
Abstract
Inulin, a naturally occurring polysaccharide and dietary ber, has garnered grow-
ing interest due to its potential in enhancing gastrointestinal health. This book
offers an in-depth study of the present status of research on inulin and its inu-
ence on gastrointestinal diseases. The book consolidates research ndings to
examine the possible therapeutic benets of inulin on various gastrointestinal
disorders, such as irritable bowel syndrome (IBS), inammatory bowel disease
(IBD), and constipation. The book discusses the mechanisms that explain the
positive benets of inulin on gastrointestinal health. It emphasizes inulin’s capac-
ity to regulate the composition of gut microbiota, stimulate the growth of bene-
cial bacteria (such as Bidobacteria), and increase the production of short-chain
fatty acids. These physiological changes help to preserve the integrity of the gut
barrier, regulate the immune system, and decrease inammation in the gastroin-
testinal tract. Furthermore, the book discusses the various obstacles and issues
related with inulin supplementation, such as individual variations in tolerance
and the need for individualized treatments. The book additionally looks at cur-
rent research endeavors focused on determining the ideal dosage, duration, and
target demographics that may derive the greatest advantages from inulin supple-
mentation. In summary, this book is a helpful resource for healthcare profession-
S. K. Kadiri · P. Tiwari (*)
Department of Pharmacology, College of Pharmaceutical Sciences, Dayananda Sagar
University, Bengaluru, Karnataka, India
D. S. Khobragade
Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research,
Sawangi (M), Wardha, Maharashtra, India
D. Sathavalli
Department of Pharmaceutics, JSS College of Pharmacy, Mysuru, Karnataka, India

216
als, researchers, and consumers seeking to understand the current scientic
evidence on the use of inulin as a viable treatment approach for different gastro-
intestinal conditions. It highlights the necessity for additional study to provide
denitive guidelines for inulin supplementation and its incorporation into dietary
recommendations for enhanced gastrointestinal health.
Keywords
Inulin · Gastrointestinal disorders · Microbiota · Inammatory bowel disease ·
Irritable bowel syndrome · Immune system
11.1 An Overview ofInulin
Inulin is a carbohydrate with a well-established history, having rst been extracted
from the plant Inula helenium, which subsequently lent its name to inulin (Ahmed
and Rashid 2019). This particular type of carbohydrate is produced by a variety of
higher plant families, totaling at least ten. Inulin is prevalent in several plants of
economic signicance, including chicory, Jerusalem artichoke, as well as staple
crops like onion, garlic, barley, rye, and wheat (Abad Alegria and Gonzalez-Vivanco
2003). Inulin is essentially a type of linear fructan, which is a naturally occurring
polysaccharide made up of chains of fructose units linked together through beta
(2→1) glycosidic bonds, typically ending with a single glucose unit connected by
an alpha (1→2) linkage at one end of the molecule (Abbasi etal. 2009; Abou-Arab
etal. 2011). This compound is a primary storage carbohydrate found in approxi-
mately 45,000 species of plants, which accounts for 15% of all owering plant spe-
cies. Notable plants with high inulin content include the tubers of the Jerusalem
artichoke (Helianthus tuberosus), dahlia (Dahlia pinnata), yacon (Polymnia sonchi-
folia), and chicory (Cichorium intybus) (Abozed etal. 2009).
Inulin molecules consist of a mix of both short and long chains of fructose mono-
mers that are conjoined through beta-congurations at the anomeric C2 position.
This particular beta-conguration renders inulin resistant to being broken down by
the enzymes in the human digestive system. As a result, inulin and its related fruc-
tans are classied as non-digestible carbohydrates (Afzal etal. 2009). The degree of
polymerization (DP) of inulin, which indicates the number of fructose units per
molecule, can range from 2 to 60, with an average DP typically between 10 and
12units. This DP value is crucial as it can inuence inulin’s functional properties
and varies depending on factors such as the plant source, time of harvest, climatic
conditions, growth period, and the duration of storage postharvest (Ahmed 2009).
Oligofructose or fructo-oligosaccharides are the shorter-chain versions of inulin,
with DP values of 10units or less. Specically, inulin derived from chicory tends to
have lower DP values in comparison to that extracted from artichokes and globe
thistle. Many plants, including chicory root, garlic, onions, leeks, bananas, and
asparagus, contain inulin, a kind of dietary ber (Albers etal. 2005). It is a member
of the fructan class of carbohydrates, which are chains of molecules of fructose.
S. K. Kadiri et al.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
